首页|期刊导航|中国普通外科杂志|常规血/尿生化指标与胰腺癌风险因果关联的孟德尔随机化分析

常规血/尿生化指标与胰腺癌风险因果关联的孟德尔随机化分析OA

Routine blood and urine biochemical biomarkers in relation to pancreatic cancer risk:a Mendelian randomization analysis

中文摘要英文摘要

背景与目的:胰腺癌(PC)早期诊断困难,现有标志物(如CA19-9)难以满足人群筛查需求.常规血/尿生化指标具备可及性强、可重复检测等优势,但其与PC风险的因果关系尚不明确.本研究基于两样本孟德尔随机化(MR)方法,系统评估35项常规生化指标与PC风险的潜在因果关联. 方法:暴露数据来源于英国生物样本库(UK Biobank)相关GWAS汇总数据,结局数据来自FinnGen R12数据库.以逆方差加权法(IVW)为主要分析方法,并结合MR-Egger、加权中位数及加权模式方法进行验证,同时开展异质性、多效性及稳健性分析. 结果:MR分析显示,肾功能相关指标与PC风险存在稳定因果关联:遗传预测的血肌酐每升高1个标准差,PC风险增加18%(OR=1.18,95%CI=1.03~1.36,P=0.019);估算肾小球滤过率(eGFR)每升高1个标准差,PC风险降低17%(OR=0.83,95%CI=0.72~0.97,P=0.016).多种敏感性分析结果一致,未发现显著异质性或水平多效性. 结论:本研究提供了肾功能相关指标与PC风险之间的遗传学因果证据,提示"肾功能轴"可能参与PC发生发展.血肌酐与eGFR有望作为PC风险分层及早期识别的潜在宿主标志物,仍需进一步机制研究与前瞻性验证.

Background and Aims:Early detection of pancreatic cancer(PC)remains challenging,and conventional biomarkers such as CA19-9 are inadequate for population screening.Routine blood and urine biochemical markers are widely accessible and reflect systemic physiological status;however,their causal relationships with PC risk remain unclear.Therefore,this study aimed to systematically evaluate the potential causal associations between 35 routine biochemical biomarkers and pancreatic cancer risk using a two-sample Mendelian randomization(MR)framework. Methods:A two-sample MR study was conducted using genome-wide association study(GWAS)summary data from the UK Biobank for 35 biochemical traits.Outcome data for PC were obtained from the FinnGen consortium(release R12).The inverse-variance weighted(IVW)method was used as the primary analysis,complemented by MR-Egger,weighted median,and weighted mode approaches.Sensitivity analyses were performed to assess robustness. Results:Two kidney function-related traits showed consistent causal associations with PC risk.Genetically predicted higher serum creatinine levels were associated with an 18%increased risk of PC per 1-standard deviation increment(OR=1.18,95%CI=1.03-1.36,P=0.019),whereas higher estimated glomerular filtration rate(eGFR)was associated with a 17%reduced risk(OR=0.83,95%CI=0.72-0.97,P=0.016).Sensitivity analyses supported the robustness of these findings,with no evidence of substantial heterogeneity or horizontal pleiotropy. Conclusions:This MR study provides genetic evidence supporting a potential causal role of kidney function-related pathways in pancreatic cancer.Serum creatinine and eGFR may serve as promising host-related biomarkers for risk stratification and early detection,warranting further mechanistic and prospective validation.

贺逸嘉;刘雍容;张欣;吴可柯

中南大学湘雅三医院 肝胆外科,湖南 长沙 410013中南大学湘雅三医院 手术中心,湖南 长沙 410013湖南省湘潭市第二人民医院 消化内科,湖南 湘潭 411100中南大学湘雅三医院 麻醉科,湖南 长沙 410013

医药卫生

胰腺肿瘤生物标记肌酸酐肾小球滤过率孟德尔随机化分析

Pancreatic NeoplasmsBiomarkersCreatinineGlomerular Filtration RateMendelian Randomization Analysis

《中国普通外科杂志》 2026 (2)

343-349,7

10.7659/j.issn.1005-6947.250598

评论